The diagnostics company Gradientech today announces the collaboration with a.d.a. SRL as commercial partner for the Italian clinical microbiology market for its QuickMIC® system for rapid antibiotic susceptibility testing of positive blood cultures. Based on a strong believe in the diagnostic product, a.d.a. SRL has also decided to make an investment in Gradientech.
Gradientech meddelar idag att den nyligen presenterade studien ”A multi-center evaluation of a novel microfluidic rapid AST assay for Gram-negative bloodstream infections” visar att bolagets ultra-snabba och precisa diagnostiksystem QuickMIC® kan mäta antibiotikaresistens och precisa linjära MIC-värden (Minimum Inhibitory Concentration) med mycket hög noggrannhet och med flera timmar kortare tid till resultat än konkurrerande AST-system (Antibiotic Susceptibility Testing).
Gradientech today announces that the recently presented abstract “A multi-center evaluation of a novel microfluidic rapid AST assay for Gram-negative bloodstream infections” concludes that its ultra-rapid and precise diagnostic system QuickMIC® can be used to determine antibiotic susceptibility and measure precise linear MIC (Minimum Inhibitory Concentration) values with very high accuracy, with time to result hours faster than competing AST (Antibiotic Susceptibility Testing) systems.
Uppsala, Sweden, 14 April 2023. Gradientech announces that it will present promising results from two collaborative studies of its ultra-rapid and precise diagnostic system QuickMIC® at the 33rd European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) in Copenhagen, Denmark 15 – 18 April 2023.
Uppsala, Sverige, 14 april 2023. Gradientech kommer att presentera lovande resultat från två samarbetsstudier med bolagets ultrasnabba och precisa diagnostiksystem QuickMIC® på European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) i Köpenhamn den 15–18 april 2023.
Gradientech’s annual report for 2022 has today been published on the company’s website.
Gradientechs årsredovisning för 2022 har idag publicerats på bolagets hemsida.
Aktieägarna i Gradientech AB, org. nr 556788-9505 (“Bolaget”), kallas härmed till årsstämma tisdagen den 9 maj 2023 klockan 17.00 i Bolagets lokaler på Dag Hammarskjölds väg 36 i Uppsala.
Gradientech will exhibit at ECCMID 2023 in Copenhagen, Denmark from April 15th to 18th. ECCMID (European Congress of Clinical Microbiology & Infectious Diseases) is one of the most comprehensive and influential congresses in the field of infectious diseases and microbiology, bringing together over 14,000 professionals from all over the world. We look forward to meeting you at […]
Gradientech kommer att ställa ut på ECCMID 2023 i Köpenhamn, Danmark den 15 till 18 april. ECCMID (European Congress of Clinical Microbiology & Infectious Diseases) är en av de största och mest betydelsefulla kongresserna inom området infektionssjukdomar och mikrobiologi. ECCMID samlar årligen över 14 000 yrkesverksamma från hela världen. Vi finns i vår monter C4-19 i […]